Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Homo sapiens

ABSTRACT: Transcriptomic studies of adult T cell leukemia and TLL1-transduced ATL cell line

PROVIDER: PRJDB18259 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	DRR573818_1.fastq.gz	Fastqsanger.gz
	DRR573818_2.fastq.gz	Fastqsanger.gz
	DRR573819_1.fastq.gz	Fastqsanger.gz
	DRR573819_2.fastq.gz	Fastqsanger.gz
	DRR573820_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 14

Similar Datasets

Homo sapiens

Project description:SNP array data for adult T-cell leukemia (ATL)

| PRJNA389274 | ENA

Homo sapiens

Project description:Epigenomic and transcriptomic studies of adult T cell leukemia

| PRJDB10016 | ENA

Homo sapiens

Project description:Expression profiles of leukemia cells of acute-type adult T-cell leukemia (ATL) patients

| PRJNA184059 | ENA

Homo sapiens

Project description:Affymetrix SNP array data for acute-type adult T-cell leukemia (ATL) samples

| PRJNA237234 | ENA

Transcription profiling of human adult T-cell leukemia/lymphoma (ATL) patients

Project description:Abstract: Adult T-cell leukemia/lymphoma (ATL) is an aggressive and fatal disease. We have examined 18 ATL patient samples using Affymetrix HG-U133A2.0 arrays. Using the BRB array program, we identified genes differentially expressed in leukemia cells compared to normal lymphocytes. Several unique genes were identified that were overexpressed in leukemia cells including TNFSF11, RGS13, MAFb, CSPG2, C/EBPalpha and TCF4. 200 of the most highly overexpressed ATL genes were analyzed by the PathwayStudio 4.0 program. ATL leukemia cells were characterized by an increase in genes linked to "central" genes CDC2/cyclin B1, SYK/LYN, PCNA and BIRC5. Because of its potential therapeutic importance, we focused our studies on the regulation and function of BIRC5, whose expression was increased in 13 of 14 leukemia samples. TCF4 reporter assays and transfection of DN-TCF4 demonstrated that TCF4 regulates BIRC5 gene expression. Functionally, transfection of ATL cells wi BIRC5 shRNA decreased BIRC5 exprression and cell viability 80%. Clinical treatment of ATL patients with Zenapax or bortezomib decreased BIRC5 expression and cell viability. These experiments represent the first direct experimental evidence that BIRC5 plays an important role in ATL cell viability and provides important insight into ATL genesis and potential targeted therapies. Experiment Overall Design: Gene expression profiles of 7 control and 18 ATL patient samples were analyzed using Affymetrix HG-U133A2.0 arrays.

2009-02-08 | E-GEOD-14317 | biostudies-arrayexpress

Gene expression profiling of ATL patients

2009-02-01 | GSE14317 | GEO

59de799a-1eed-4bf8-9976-644a21c44c2d - samples

Project description:This dataset includes 10 RNA-sequencing (RNA-seq) data for 9 primary tumors and 1 cell line from adult T-cell leukemia/lymphoma (ATL).

| EGAD00001004937 | EGA

Homo sapiens

Project description:miRNA expression profiling in Adult T-cell Leukemia (ATL) cells and in Normal CD4+ T-cells

| PRJNA145549 | ENA

RNA-sequencing of adult T-cell leukemia/lymphoma samples

Project description:Adult T-cell leukemia/lymphoma (ATL) is a highly aggressive hematological malignancy derived from mature CD4+ T-lymphocytes. In this study, we performed RNA-sequencing (RNA-seq) analysis for ATL samples including 9 primary tumors and 1 ATL cell line to clarify gene expression profiles in this disease.

| EGAS00001003575 | EGA

Molecular targets of HIV integrase inhibitor, MK-2048, on ATL cells

Project description:Adult T-cell Leukemia (ATL) is a highly chemoresistant malignancy of peripheral T lymphocytes, associated with retrovirus human T-cell leukemia virus type I (HTLV-1). To elucidate the complex molecular mechanism of anti-Growth effect of the HIV integrase inhibitor, MK-2048 in ATL cells, we attempted to perform gene expression profiling.

2020-01-01 | GSE113265 | GEO

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data